Advil Congestion effort ties traffic gridlock to cold and flu misery

Share this article:
Advil Congestion effort ties traffic gridlock to cold and flu misery
Advil Congestion effort ties traffic gridlock to cold and flu misery
Don't tell the New York Post, but Pfizer is boosting bike lanes as part of an Advil promotion.

Pfizer Consumer Healthcare donated special snow removal equipment for bike lanes to Chicago, which ranks Number One in the country for traffic congestion, to promote Advil Congestion Relief. Chicago Bears legend and Pro Football Hall of Famer Richard Dent presided over the giveaway of the equipment and 100 new bikes last week. The company is running ads for the brand under the tagline “The Right Relief for the Real Problem, and will be holding similar events in communities around the country as part of its Advil Congestion Relief Project this winter. Visitors to the campaign website, CongestionReliefProject.com, can share their community's congestion relief needs for a chance to win $30,000 towards local congestion relief efforts.

“We are passionate about finding the right relief for the real problem for consumers wherever they need it, from their noses to their communities,” said Kristin Shea, franchise head for upper respiratory and allergy at Pfizer Consumer Healthcare. “We're excited to be hitting the road with the Advil Congestion Relief Project this cold and flu season and look forward to seeing the stories our consumers will share with us about their communities.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...